These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23516071)

  • 21. Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions.
    Pellise M; Burgess NG; Tutticci N; Hourigan LF; Zanati SA; Brown GJ; Singh R; Williams SJ; Raftopoulos SC; Ormonde D; Moss A; Byth K; P'Ng H; Mahajan H; McLeod D; Bourke MJ
    Gut; 2017 Apr; 66(4):644-653. PubMed ID: 26786685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein accumulation and colonic adenoma recurrence.
    Triantafyllou K; Paspatis GA; Zizi A; Papatheodoridis GV; Tzouvala M; Chlouverakis GJ; Elemenoglou I; Karamanolis DG
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):547-52. PubMed ID: 10755260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
    Chung SJ; Kim YS; Yang SY; Song JH; Kim D; Park MJ; Kim SG; Song IS; Kim JS
    Gut; 2011 Nov; 60(11):1537-43. PubMed ID: 21427200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term outcomes of colon polyps with high grade dysplasia following endoscopic resection.
    Chang JJ; Chien CH; Chen SW; Chen LW; Liu CJ; Yen CL
    BMC Gastroenterol; 2020 Nov; 20(1):376. PubMed ID: 33172387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first year follow-up after colorectal adenoma polypectomy is important: a multiple-center study in symptomatic hospital-based individuals in China.
    Gao QY; Chen HM; Sheng JQ; Zheng P; Yu CG; Jiang B; Fang JY
    Front Med China; 2010 Dec; 4(4):436-42. PubMed ID: 21128011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma.
    Kawasaki Y; Monden T; Morimoto H; Murotani M; Miyoshi Y; Kobayashi T; Shimano T; Mori T
    Am J Clin Pathol; 1992 Feb; 97(2):244-9. PubMed ID: 1546693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center.
    Vemulapalli KC; Rex DK
    Gastrointest Endosc; 2014 Aug; 80(2):299-306. PubMed ID: 24796960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the risk for metachronous colorectal neoplasms following intestinal polypectomy: a clinical, endoscopic and pathological study.
    Fornasarig M; Valentini M; Poletti M; Carbone A; Bidoli E; Sozzi M; Cannizzaro R
    Hepatogastroenterology; 1998; 45(23):1565-72. PubMed ID: 9840106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas.
    Hassan C; Gimeno-García A; Kalager M; Spada C; Zullo A; Costamagna G; Senore C; Rex DK; Quintero E
    Aliment Pharmacol Ther; 2014 May; 39(9):905-12. PubMed ID: 24593121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Colon Polypectomy - And Then?].
    Berger AW; Ettrich TJ; Dollinger MM
    Zentralbl Chir; 2015 Aug; 140(4):426-34. PubMed ID: 23846540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study.
    Song M; Emilsson L; Bozorg SR; Nguyen LH; Joshi AD; Staller K; Nayor J; Chan AT; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):537-547. PubMed ID: 32192628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.
    Gupta S; Sun H; Yi S; Storm J; Xiao G; Balasubramanian BA; Zhang S; Ashfaq R; Rockey DC
    Cancer Prev Res (Phila); 2014 Oct; 7(10):1023-34. PubMed ID: 25092825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
    Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
    Winawer SJ; Zauber AG; Fletcher RH; Stillman JS; O'Brien MJ; Levin B; Smith RA; Lieberman DA; Burt RW; Levin TR; Bond JH; Brooks D; Byers T; Hyman N; Kirk L; Thorson A; Simmang C; Johnson D; Rex DK; ;
    Gastroenterology; 2006 May; 130(6):1872-85. PubMed ID: 16697750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between body size and colorectal adenoma recurrence.
    Jacobs ET; Martínez ME; Alberts DS; Jiang R; Lance P; Lowe KA; Thompson PA
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):982-90. PubMed ID: 17553754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.
    Su T; Washington MK; Ness RM; Rex DK; Smalley WE; Ulbright TM; Cai Q; Zheng W; Shrubsole MJ
    Mol Carcinog; 2017 Feb; 56(2):761-773. PubMed ID: 27479195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of the early development of advanced metachronous colon adenomas.
    Triantafyllou K; Papatheodoridis GV; Paspatis GA; Vasilakaki TH; Elemenoglou I; Karamanolis DG
    Hepatogastroenterology; 1997; 44(14):533-8. PubMed ID: 9164533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.